124 related articles for article (PubMed ID: 24132302)
1. Substitution of gadolinium ethylenediaminetetraacetate with phosphites: towards gadolinium deposit in nephrogenic systemic fibrosis.
Gao S; Chen ML; Zhou ZH
Dalton Trans; 2014 Jan; 43(2):639-45. PubMed ID: 24132302
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.
Gao S; George SJ; Zhou ZH
Dalton Trans; 2016 Mar; 45(12):5388-94. PubMed ID: 26906409
[TBL] [Abstract][Full Text] [Related]
3. Isolations and characterization of highly water-soluble dimeric lanthanide citrate and malate with ethylenediaminetetraacetate.
Chen ML; Gao S; Zhou ZH
Dalton Trans; 2012 Jan; 41(4):1202-9. PubMed ID: 22116197
[TBL] [Abstract][Full Text] [Related]
4. The effect of pyridinecarboxylate chelating groups on the stability and electronic relaxation of gadolinium complexes.
Chatterton N; Gateau C; Mazzanti M; Pécaut J; Borel A; Helm L; Merbach A
Dalton Trans; 2005 Mar; (6):1129-35. PubMed ID: 15739017
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand.
Pálinkás Z; Baranyai Z; Brücher E; Rózsa B
Inorg Chem; 2011 Apr; 50(8):3471-8. PubMed ID: 21405037
[TBL] [Abstract][Full Text] [Related]
6. Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands.
Baranyai Z; Pálinkás Z; Uggeri F; Maiocchi A; Aime S; Brücher E
Chemistry; 2012 Dec; 18(51):16426-35. PubMed ID: 23139193
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
8. Structural, kinetic, and thermodynamic characterization of the interconverting isomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
Tyeklar Z; Dunham SU; Midelfort K; Scott DM; Sajiki H; Ong K; Lauffer RB; Caravan P; McMurry TJ
Inorg Chem; 2007 Aug; 46(16):6621-31. PubMed ID: 17625838
[TBL] [Abstract][Full Text] [Related]
9. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
Telgmann L; Sperling M; Karst U
Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
Fretellier N; Bouzian N; Parmentier N; Bruneval P; Jestin G; Factor C; Mandet C; Daubiné F; Massicot F; Laprévote O; Hollenbeck C; Port M; Idée JM; Corot C
Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
[TBL] [Abstract][Full Text] [Related]
11. Structure, stability, dynamics, high-field relaxivity and ternary-complex formation of a new tris(aquo) gadolinium complex.
Nonat A; Fries PH; Pécaut J; Mazzanti M
Chemistry; 2007; 13(30):8489-506. PubMed ID: 17659512
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause.
Provenzale JM
AJR Am J Roentgenol; 2008 Dec; 191(6):1867-9. PubMed ID: 19020262
[No Abstract] [Full Text] [Related]
14. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry.
Telgmann L; Faber H; Jahn S; Melles D; Simon H; Sperling M; Karst U
J Chromatogr A; 2012 Jun; 1240():147-55. PubMed ID: 22525874
[TBL] [Abstract][Full Text] [Related]
15. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
Abraham JL; Edward M
AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
[No Abstract] [Full Text] [Related]
16. Novel polycarboxylated EDTA-type cyclodextrins as ligands for lanthanide binding: study of their luminescence, relaxivity properties of Gd(iii) complexes, and PM3 theoretical calculations.
Maffeo D; Lampropoulou M; Fardis M; Lazarou YG; Mavridis IM; Mavridou DA; Urso E; Pratsinis H; Kletsas D; Yannakopoulou K
Org Biomol Chem; 2010 Apr; 8(8):1910-21. PubMed ID: 20449498
[TBL] [Abstract][Full Text] [Related]
17. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium contrast agent associated stimulation of human fibroblast collagen production.
MacNeil S; Bains S; Johnson C; Idée JM; Factor C; Jestin G; Fretellier N; Morcos SK
Invest Radiol; 2011 Nov; 46(11):711-7. PubMed ID: 21826007
[TBL] [Abstract][Full Text] [Related]
19. Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis.
Wiginton CD
AJR Am J Roentgenol; 2008 Dec; 191(6):1864-6. PubMed ID: 19020261
[No Abstract] [Full Text] [Related]
20. Transformation of a layered zinc phosphite to a three-dimensional open-framework structure with intersecting 16- and 12-ring channels.
Lin Z; Nayek HP; Dehnen S
Inorg Chem; 2009 Apr; 48(8):3517-9. PubMed ID: 19309107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
